Unbiased clustering approach facilitates the VUS Classification in a Patient with CTLA-4 Haploinsufficiency

被引:0
|
作者
Fernandez, Isabel [1 ]
Starich, Olivia [2 ]
Ehler, Angelica [3 ]
Bruckner, Anna [3 ]
Shirley, Joel [3 ]
Knight, Vijaya [3 ]
Abbott, Jordan [3 ]
机构
[1] Univ Colorado, Anschutz, Boulder, CO USA
[2] Univ Colorado, Sch Med, Boulder, CO 80309 USA
[3] Univ Colorado, Sch Med, Childrens Hosp Colorado, Boulder, CO USA
关键词
CTLA-4; primary immunodeficiency; AIRE; clustering;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
167
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 50 条
  • [41] CTLA-4 inhibition facilitates follicular T and B cell interaction and the production of tumor-specific antibodies
    Jo, Areum
    Jeong, Dasom
    Eum, Hye Hyeon
    Kim, Nayoung
    Na, Minsu
    Kang, Huiram
    Lee, Hae-Ock
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (09) : 1964 - 1976
  • [42] Blockade of PD-1 and CTLA-4: A potent immunotherapeutic approach for hepatocellular carcinoma
    Hou, Kai
    Xu, Xiaohui
    Ge, Xin
    Jiang, Jiacen
    Ouyang, Fan
    BIOFACTORS, 2024, 50 (02) : 250 - 265
  • [43] Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency
    Nishimura, Masashi
    Miyata, Jun
    Tanigaki, Tomomi
    Nomura, Sakika
    Serizawa, Yusuke
    Igarashi, Syunya
    Itou, Koki
    Ohno, Tomohiro
    Kurata, Yuhei
    Kimizuka, Yoshifumi
    Fujikura, Yuji
    Sekinaka, Yujin
    Sekinaka, Kanako
    Matsukuma, Susumu
    Nonoyama, Shigeaki
    Kawana, Akihiko
    INTERNAL MEDICINE, 2023, 62 (06) : 871 - 875
  • [44] A Mathematical Model for Predicting Patient Responses to Combined Radiotherapy with CTLA-4 Immune Checkpoint Inhibitors
    Kim, Yongjin
    Choe, Bo-Young
    Suh, Tae Suk
    Sung, Wonmo
    CELLS, 2023, 12 (09)
  • [45] Case report: Pediatric patient with severe clinical course of CTLA-4 insufficiency treated with HSCT
    Drabko, Katarzyna
    Zarychta, Julia
    Kowalczyk, Adrian
    Cienkusz, Magdalena
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4
    Lee, Sangmoon
    Moon, Jin Soo
    Lee, Cho-Rong
    Kim, Hye-Eun
    Baek, Sun-Mi
    Hwang, Solha
    Kang, Gyeong Hoon
    Seo, Jeong Kee
    Shin, Choong Ho
    Kang, Hyoung Jin
    Ko, Jae Sung
    Park, Sung Gyoo
    Choi, Murim
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (01) : 327 - 330
  • [47] Blocking of CTLA-4 on lymphocytes improves the sensitivity of lymphocyte transformation tests in a patient with nickel allergy
    Sugita, Kazunari
    Kabashima, Kenji
    Sawada, Yu
    Haruyama, Sanehito
    Yoshioka, Manabu
    Mori, Tomoko
    Kobayashi, Miwa
    Ogasawara, Kouetsu
    Tokura, Yoshiki
    EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (02) : 268 - 269
  • [48] Elaborating on anti CTLA-4 mechanisms of action using an agent-based modeling approach
    Azarov, Ivan
    Helmlinger, Gabriel
    Kosinsky, Yuri
    Peskov, Kirill
    FRONTIERS IN APPLIED MATHEMATICS AND STATISTICS, 2022, 8
  • [49] New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient
    Miserocchi, Elisabetta
    Cimminiello, Carolina
    Mazzola, Marco
    Russo, Vincenzo
    Modorati, Giulio M.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2015, 50 (01): : E2 - E4
  • [50] CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis
    Fedele, A. L.
    Alivernini, S.
    Gremese, E.
    Ferraccioli, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 315 - 317